SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-056556
Filing Date
2021-04-28
Accepted
2021-04-28 16:09:59
Documents
63
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q inva-20210331x10q.htm   iXBRL 10-Q 1374845
2 EXHIBIT 10.1 inva-20210331xex10d1.htm EX-10.1 107151
3 EXHIBIT 31.1 inva-20210331xex31d1.htm EX-31.1 10029
4 EXHIBIT 31.2 inva-20210331xex31d2.htm EX-31.2 8904
5 EXHIBIT 32 inva-20210331xex32.htm EX-32 14397
  Complete submission text file 0001104659-21-056556.txt   6401789

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA inva-20210331.xsd EX-101.SCH 42010
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inva-20210331_cal.xml EX-101.CAL 59935
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inva-20210331_def.xml EX-101.DEF 177507
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE inva-20210331_lab.xml EX-101.LAB 389160
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inva-20210331_pre.xml EX-101.PRE 324331
11 EXTRACTED XBRL INSTANCE DOCUMENT inva-20210331x10q_htm.xml XML 1224002
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 21864321
SIC: 2834 Pharmaceutical Preparations